As an FDA-approved option, Semaglutide GLP-1 targets weight loss in adults struggling with obesity or related health conditions
You might feel more nauseous when you start the treatment, because it takes your body around four weeks to get used to the medication
Small shifts in storage conditions, thaw-refreeze practices, or internal standard selection can accumulate into significant variability, making it difficult to interpret subtle but biologically meaningful differences in endpoints such as glucose tolerance, body-composition proxies, or signaling-pathway activation
The current evidence indicates promising potential, however a broader validation is required, specifically in the context of PsA
As the industry realigns, our presence in the GLP-1 space isnt just symbolic its a clear statement